These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15526831)

  • 1. Clinical trials referral resource. Current clinical trials in mesothelioma.
    Saxman S; Schoenfeldt M
    Oncology (Williston Park); 2004 Sep; 18(10):1280, 1283, 1285. PubMed ID: 15526831
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials referral resource. Current clinical trials in rhabdomyosarcoma.
    Anderson BD; Schoenfeldt M
    Oncology (Williston Park); 2005 Sep; 19(10):1319-20, 1330. PubMed ID: 16285226
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials referral resource. Current phase II and phase III clinical trials for pancreatic cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Jul; 18(8):1008, 1013-4, 1016. PubMed ID: 15328895
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer.
    Mooney MM; Schoenfeldt M
    Oncology (Williston Park); 2004 Oct; 18(11):1396, 1401, 1404 passim. PubMed ID: 15609469
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials referral resource. Current clinical trials in myelodysplastic syndrome.
    Davis T; Schoenfeldt M; Chevalier SM
    Oncology (Williston Park); 2005 Jul; 19(8):1035-6, 1038. PubMed ID: 16131045
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials referral resource. Current clinical trials of thalidomide.
    Streicher HZ; Vereshchagina LA; Schoenfeldt M
    Oncology (Williston Park); 2003 Mar; 17(3):369-71, 374-5, 379-80. PubMed ID: 12661268
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials referral resource. Current phase III breast cancer clinical trials.
    Zujewski J; Enos RA; Mason S
    Oncology (Williston Park); 2006 Jun; 20(7):696, 700, 702. PubMed ID: 16841794
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials referral resource. Multiple myeloma and Waldenström's macroglobulinemia phase III trials.
    Cheson BD; Phillips PH
    Oncology (Williston Park); 1994 Jul; 8(7):45, 48-50. PubMed ID: 7917838
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancer.
    Abrams JS; Enos RA; Schoenfeldt M
    Oncology (Williston Park); 2004 Apr; 18(4):463-4, 467-8, 470. PubMed ID: 15134354
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials referral resource. Current phase III clinical trials for adults with leukemia or lymphoma.
    Davis T; Schoenfeldt M
    Oncology (Williston Park); 2004 Jan; 18(1):62, 65, 69. PubMed ID: 14768407
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials.
    Farrington P; Miller E
    Methods Mol Med; 2003; 87():335-52. PubMed ID: 12958466
    [No Abstract]   [Full Text] [Related]  

  • 12. Stat bite: Treatment trials in the PDQ clinical trials database, by phase.
    J Natl Cancer Inst; 2004 Sep; 96(18):1355. PubMed ID: 15367566
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials part II.
    Burgess G
    Surviv News (Atlanta Ga); 2002 Jul; ():12. PubMed ID: 12238473
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization, more funds on horizon for clinical trials.
    McNeil C
    J Natl Cancer Inst; 2005 Apr; 97(8):555-7. PubMed ID: 15840874
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies--what is the putting of the question?].
    Guttenberger R
    Strahlenther Onkol; 1999 Apr; 175 Suppl 1():14-6. PubMed ID: 10230452
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methodological approaches of clinical studies with targeted therapies].
    Penel N; Saleron J; Lansiaux A; Clisant S; Adenis A; Fournier C; Duhamel A; Bonneterre J
    Bull Cancer; 2008 Feb; 95(2):185-90. PubMed ID: 18304903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 25-year review of sequential methodology in clinical studies.
    Todd S
    Stat Med; 2007 Jan; 26(2):237-52. PubMed ID: 17139691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M; Daniele B; Gallo C; Perrone F
    J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract]   [Full Text] [Related]  

  • 20. Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer Group.
    Francart J; Legrand C; Sylvester R; Van Glabbeke M; van Meerbeeck JP; Robert A
    J Clin Oncol; 2006 Jul; 24(19):3007-12. PubMed ID: 16809726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.